Alkeon Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.3M | Hold |
1,685,729
| – | – | 0.1% | 53 |
|
|
2025
Q1 | $61M | Sell |
1,685,729
-987
| -0.1% | -$35.7K | 0.13% | 50 |
|
|
2024
Q4 | $71M | Sell |
1,686,716
-1,325,000
| -44% | -$55.7M | 0.14% | 45 |
|
|
2024
Q3 | $167M | Buy |
3,011,716
+769,884
| +34% | +$42.8M | 0.29% | 36 |
|
|
2024
Q2 | $92.1M | Hold |
2,241,832
| – | – | 0.15% | 46 |
|
|
2024
Q1 | $105M | Hold |
2,241,832
| – | – | 0.18% | 44 |
|
|
2023
Q4 | $107M | Buy |
2,241,832
+298,017
| +15% | +$14.3M | 0.24% | 37 |
|
|
2023
Q3 | $69.3M | Hold |
1,943,815
| – | – | 0.12% | 52 |
|
|
2023
Q2 | $89.7M | Buy |
1,943,815
+98,141
| +5% | +$4.53M | 0.16% | 48 |
|
|
2023
Q1 | $74M | Sell |
1,845,674
-8,653
| -0.5% | -$347K | 0.16% | 51 |
|
|
2022
Q4 | $85.9M | Sell |
1,854,327
-357,632
| -16% | -$16.6M | 0.33% | 48 |
|
|
2022
Q3 | $91.6M | Sell |
2,211,959
-256,171
| -10% | -$10.6M | 0.3% | 54 |
|
|
2022
Q2 | $147M | Buy |
2,468,130
+100,000
| +4% | +$5.97M | 0.4% | 37 |
|
|
2022
Q1 | $172M | Buy |
2,368,130
+60,000
| +3% | +$4.36M | 0.34% | 49 |
|
|
2021
Q4 | $194M | Hold |
2,308,130
| – | – | 0.36% | 53 |
|
|
2021
Q3 | $208M | Buy |
2,308,130
+394,482
| +21% | +$35.6M | 0.35% | 55 |
|
|
2021
Q2 | $182M | Buy |
1,913,648
+599,791
| +46% | +$57.2M | 0.27% | 57 |
|
|
2021
Q1 | $150M | Buy |
1,313,857
+3,012
| +0.2% | +$343K | 0.22% | 63 |
|
|
2020
Q4 | $181M | Sell |
1,310,845
-568,375
| -30% | -$78.7M | 0.3% | 52 |
|
|
2020
Q3 | $154M | Buy |
1,879,220
+100,000
| +6% | +$8.22M | 0.29% | 50 |
|
|
2020
Q2 | $139M | Buy |
1,779,220
+158,687
| +10% | +$12.4M | 0.35% | 48 |
|
|
2020
Q1 | $72M | Buy |
1,620,533
+240,000
| +17% | +$10.7M | 0.31% | 52 |
|
|
2019
Q4 | $59M | Sell |
1,380,533
-206,200
| -13% | -$8.81M | 0.22% | 60 |
|
|
2019
Q3 | $67.9M | Buy |
1,586,733
+115,000
| +8% | +$4.92M | 0.24% | 55 |
|
|
2019
Q2 | $93.5M | Hold |
1,471,733
| – | – | 0.37% | 40 |
|
|
2019
Q1 | $102M | Buy |
1,471,733
+652,207
| +80% | +$45.2M | 0.51% | 31 |
|
|
2018
Q4 | $35.6M | Buy |
819,526
+78,205
| +11% | +$3.4M | 0.23% | 58 |
|
|
2018
Q3 | $56.6M | Buy |
741,321
+250,025
| +51% | +$19.1M | 0.27% | 46 |
|
|
2018
Q2 | $37.8M | Buy |
+491,296
| New | +$37.8M | 0.18% | 59 |
|